Thursday, March 31, 2016

Cipla acquires two U.S. generic drug companies

Mumbai based Multinational Pharmacy company Cipla has acquired two US Drug companies namely InvaGen and Exelan pharmaceuticals for $550 million this deal announced last September .
  • The combined revenue of these companies in 2015 was $230 million and this deal increase the market revenue to 20 % over next few years of present 8%.
  • This move comes in pipeline to increase the presence of Cipla in largest Pharmaceuticals market and also to introduce new products in oncology and diabetes

No comments:

Post a Comment